Interest of Anti-telomerase T CD4 Immune Responses for Predicting the Effectiveness of Immunotherapies Targeting PD1 / PDL1
Clinical trial NCT02840058 · COMPLETED
Trial details
- NCT number
- NCT02840058
- Sponsor
- Centre Hospitalier Universitaire de Besancon
- Status
- COMPLETED
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2016-08-31
- Primary completion
- 2024-07-23
- Enrollment
- 295
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.